Takeda Pharmaceutical Company Limited Cash Flows From Used In Operations
Takeda Pharmaceutical Company Limited (TAK) reported Cash Flows From Used In Operations of JPY 1.21 trillion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:CashFlowsFromUsedInOperations · last filed 2025-06-25
| Period end | Cash Flows From Used In Operations 12 month |
|---|---|
| 2025-03-31 | 1.21T JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 918.38B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 1.16T JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 1.26T JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 1.21T JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 896.52B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 373.39B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 407.74B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 302.11B JPY 20-F · filed 2019-06-27 |